This year the annual Vaccinology course hosted by IVI will be in person and is a great opportunity to learn about the latest developments in vaccinology. A fellowship programme is available and applications need to be submitted by 13th June 11.59 KST for a fellowship which is available for those from low and middle income …
THECA News – Cost of Illness study starts in DRC
The TCV Vaccination Trial has now completed recruiting children in Ghana – congratulations to all who have been involved – the site teams and all the families and children who participated. In DRC, Typhoid Conjugate Vaccinations (TCV) are now being offered at two health centres in the Kisantu Health Zone with plans to extend to …
Typhoid TCV Mass Vaccination Campaign is launched in DRC
On 10th February 2022 the mass vaccination campaign was launched and vaccination have started in the Kisantu Health Zone. The first vaccinations are being administered at the biggest health centre, Nkandu 1, and then will be rolled out to a further nineteen health centres. This important milestone for TyVECO and the fight to protect children …
Typhoid TCV Mass Vaccination Campaign is launched in DRCRead More
THECA Annual Consortium Meeting 2022
New Madagascan Institute for Vaccine Research Inaugurated on 10 December 2021 THECA welcomed the new year in with its Annual Consortium Meeting on 24th January 2022. Sadly the meeting was held online rather than in person but this was compensated for by the many exciting reports on the achievements of the THECA partners over the …
THECA Vaccination Trial Starts in Ghana
by Professor Ellis Owusu-Dabo, Ghana Principal Investigator and Kwame Nkrumah University of Science and Technology, Kumasi, Ghana August 23, 2021 marks a monumental and great day for Africa! Amidst the COVID-19 pandemic, Ghana undertook the herculean task of launching TyVEGHA, the first cluster-randomized, controlled Phase IV study of Typbar TCV® typhoid conjugate vaccine (TCV) in Africa. This study …